[212Pb]Rituximab treatment to overcome hematological toxicity in non-Hodgkin's lymphoma Oct. 16, 2019
New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics Oct. 16, 2019
Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida Oct. 16, 2019
RSS